Appili Therapeutics Inc. (APLIF)
OTCMKTS
· Delayed Price · Currency is USD
0.0220
0.00 (0.00%)
Apr 23, 2025, 4:00 PM EDT
Appili Therapeutics Revenue
Appili Therapeutics had revenue of 108.36K CAD in the quarter ending December 31, 2024, a decrease of -77.35%. This brings the company's revenue in the last twelve months to 124.75K, down -89.15% year-over-year. In the fiscal year ending March 31, 2024, Appili Therapeutics had annual revenue of 827.41K with 147.60% growth.
Revenue (ttm)
124.75K CAD
Revenue Growth
-89.15%
P/S Ratio
25.18
Revenue / Employee
13.86K CAD
Employees
9
Market Cap
2.18M USD
Revenue Chart
* This company reports financials in CAD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SS Innovations International | 20.65M |
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
Glass House Brands | 200.90M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Appili Therapeutics News
- 22 days ago - Appili President and CEO, Don Cilla to Join Aditxt CEO, Amro Albanna for Aditxt Weekly Update on April 4, 2025 - GlobeNewsWire
- 5 weeks ago - Appili Therapeutics Announces Submission of U.S. Federal Government Funding Proposals and Provides Corporate and Aditxt Transaction Update - GlobeNewsWire
- 2 months ago - Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2025 - GlobeNewsWire
- 5 months ago - Appili Therapeutics Announces Receipt of Final Court Order for Arrangement with Aditxt, Inc. - GlobeNewsWire
- 5 months ago - Appili Therapeutics reports Q2 results - Seeking Alpha
- 5 months ago - Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025 - GlobeNewsWire
- 6 months ago - Aditxt's Target Acquisition Appili Therapeutics Announces Results of Special Meeting of Shareholders - Business Wire
- 6 months ago - Appili Therapeutics Announces Results of Special Meeting of Shareholders - GlobeNewsWire